LeonaBio (LONA) Capital Expenditures (2020 - 2024)

LeonaBio (LONA) has reported Capital Expenditures for 5 consecutive years, with $28000.0 the latest figure, recorded in Q2 2024.

• In Q2 2024, Capital Expenditures fell 15.15% year-over-year to $28000.0; the TTM figure through Dec 2024 stood at $33000.0 (down 89.14% YoY), while the FY2024 annual figure was $33000.0, down 89.14% from the prior year.
• Capital Expenditures advanced to $28000.0 in Q2 2024 per LONA's latest filing, from $5000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $2.3 million in Q4 2020 and bottomed at $1000.0 in Q4 2022.
• Historically, Capital Expenditures has averaged $357533.3 across 5 years, with a median of $128000.0 in 2021.
• On a YoY basis, Capital Expenditures climbed as much as 1207.02% in 2022 and fell as far as 99.9% in 2022.
• LeonaBio's Capital Expenditures stood at $2.3 million in 2020, then slumped by 54.46% to $1.0 million in 2021, then tumbled by 99.9% to $1000.0 in 2022, then soared by 2900.0% to $30000.0 in 2023, then slipped by 6.67% to $28000.0 in 2024.
• Business Quant data shows LONA's Capital Expenditures at $28000.0 in Q2 2024, $5000.0 in Q1 2024, and $30000.0 in Q3 2023.